16621

212107

VAISHALI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VAISHALI PHARMA LIMITED Share Price Update

As of the latest trading session, VAISHALI PHARMA LIMITED is trading at ₹7.19, up by ₹0.21 or 3.00% from its previous close. The stock has moved between ₹7.01 and ₹7.28 today. Over the past year, the stock has delivered a return of -44.51%. In the last month, it has returned -5.38%.

VAISHALI PHARMA LIMITED performance

Today’s low Today’s high
₹ 7.01 ₹ 7.28
₹ 6.98
52 week low 52 week high
₹ 4.75 ₹ 13.59
₹ 6.98
Open Price ₹ 7.28
Prev. Close ₹ 6.98
Volume (Shares) 58427.00
Total traded value ₹ 4.07
Upper Circuit ₹ 7.32
Lower Circuit ₹ 6.64
info

Investment Returns

Over 1 Month -5.38% Over 3 Months 3.53% Over 6 Months -19.84% Over 1 Year -44.51%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VAISHALI PHARMA LIMITED fundamentals


  • Market cap (Cr) 91.10
  • P/E Ratio (TTM) -175.75
  • Beta 1.19
  • Book Value / share 5.16
  • Return on equity 1.52%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.27
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

VAISHALI PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 26.93
Operating Expense 28.00
Net Profit 0.27
Net Profit Margin (%) 1.00
Earnings Per Share (EPS) 0.02
EBITDA 1.05
Effective Tax Rate (%) -50.00
Particulars DEC 2025 (Values in Cr)
Revenue 24.65
Operating Expense 23.73
Net Profit 1.30
Net Profit Margin (%) 5.27
Earnings Per Share (EPS) 0.10
EBITDA 2.46
Effective Tax Rate (%) 28.02
Particulars SEP 2025 (Values in Cr)
Revenue 33.45
Operating Expense 32.62
Net Profit 1.18
Net Profit Margin (%) 3.52
Earnings Per Share (EPS) -0.49
EBITDA 2.23
Effective Tax Rate (%) 28.31
Particulars JUN 2025 (Values in Cr)
Revenue 23.75
Operating Expense 22.84
Net Profit 1.28
Net Profit Margin (%) 5.38
Earnings Per Share (EPS) 0.10
EBITDA 2.21
Effective Tax Rate (%) 26.43
Particulars MAR 2025 (Values in Cr)
Revenue 32.25
Operating Expense 38.84
Net Profit -4.29
Net Profit Margin (%) -13.30
Earnings Per Share (EPS) -0.33
EBITDA -5.03
Effective Tax Rate (%) 23.39
Particulars MAR 2026 (Values in Cr)
Revenue 108.77
Operating Expense 107.22
Net Profit 4.03
Net Profit Margin (%) 3.70
Earnings Per Share (EPS) 0.31
EBITDA 7.94
Effective Tax Rate (%) 25.23
Particulars MAR 2025 (Values in Cr)
Revenue 99.03
Operating Expense 101.00
Net Profit 0.82
Net Profit Margin (%) 0.82
Earnings Per Share (EPS) 0.06
EBITDA 3.30
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 86.28
Operating Expense 87.39
Net Profit 0.72
Net Profit Margin (%) 0.83
Earnings Per Share (EPS) 0.67
EBITDA 3.17
Effective Tax Rate (%) 22.58
Particulars MAR 2023 (Values in Cr)
Revenue 69.66
Operating Expense 63.05
Net Profit 6.60
Net Profit Margin (%) 9.47
Earnings Per Share (EPS) 6.26
EBITDA 11.36
Effective Tax Rate (%) 25.31
Particulars MAR 2022 (Values in Cr)
Revenue 75.82
Operating Expense 71.88
Net Profit 4.02
Net Profit Margin (%) 5.30
Earnings Per Share (EPS) 3.82
EBITDA 8.65
Effective Tax Rate (%) 29.66
Particulars MAR 2025 (Values in Cr)
Book Value / Share 4.98
ROE % 1.52
ROCE % 4.92
Total Debt to Total Equity 0.24
EBITDA Margin 3.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.41
ROE % 1.73
ROCE % 5.71
Total Debt to Total Equity 0.34
EBITDA Margin 4.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 38.43
ROE % 19.73
ROCE % 21.59
Total Debt to Total Equity 0.53
EBITDA Margin 16.67
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.99
ROE % 16.48
ROCE % 18.70
Total Debt to Total Equity 0.79
EBITDA Margin 11.43
Particulars MAR 2021 (Values in Cr)
Book Value / Share 21.26
ROE % 4.79
ROCE % 10.23
Total Debt to Total Equity 0.80
EBITDA Margin 8.29
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.84
Total Assets 109.84
Total Liabilities 109.84
Total Equity 64.91
Share Outstanding 13
Price to Book Ratio 2.53
Return on Assets (%) 0.74
Return on Capital (%) 1.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.57
Total Assets 79.95
Total Liabilities 79.95
Total Equity 42.83
Share Outstanding 1
Price to Book Ratio 3.50
Return on Assets (%) 0.89
Return on Capital (%) 1.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.98
Total Assets 78.89
Total Liabilities 78.89
Total Equity 40.53
Share Outstanding 1
Price to Book Ratio 3.80
Return on Assets (%) 8.36
Return on Capital (%) 12.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.35
Total Assets 81.62
Total Liabilities 81.62
Total Equity 26.35
Share Outstanding 1
Price to Book Ratio 2.65
Return on Assets (%) 4.92
Return on Capital (%) 8.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 86.12
Total Liabilities 86.12
Total Equity 22.41
Share Outstanding 1
Price to Book Ratio 1.53
Return on Assets (%) 1.21
Return on Capital (%) 2.62
Particulars MAR 2025 (Values in Cr)
Net Income 1.22
Cash from Operations -17.68
Cash from Investing -0.18
Cash from Financing 18.49
Net change in Cash 0.26
Free Cash Flow -17.38
Particulars MAR 2024 (Values in Cr)
Net Income 0.92
Cash from Operations 3.08
Cash from Investing 1.20
Cash from Financing -1.41
Net change in Cash 0.59
Free Cash Flow 3.19
Particulars MAR 2023 (Values in Cr)
Net Income 8.84
Cash from Operations 2.64
Cash from Investing 0.28
Cash from Financing -1.73
Net change in Cash -0.37
Free Cash Flow 2.94
Particulars MAR 2022 (Values in Cr)
Net Income 5.72
Cash from Operations 2.14
Cash from Investing -0.84
Cash from Financing 0.41
Net change in Cash 0.88
Free Cash Flow 3.01
Particulars MAR 2021 (Values in Cr)
Net Income 1.40
Cash from Operations 2.07
Cash from Investing -0.11
Cash from Financing -1.81
Net change in Cash 0.08
Free Cash Flow 2.20
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 14.58 1.70 270.44 23.12 38.50
BLISS GVS PHARMA LTD. 402.00 32.52 3.56 4252.72 118.35 437.40
CIPLA LTD. 1390.85 27.54 3.26 112352.94 1165.55 1672.20
FERMENTA BIOTECH LIMITED 300.35 13.25 2.17 883.96 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 24.68 4.54 270.44 23.12 38.50
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8724.25 113.94 24.98 21810.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 402.00 43.23 3.68 4252.72 118.35 437.40

VAISHALI PHARMA LIMITED shareholding pattern

Holding
68.39%
31.6%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

VAISHALI PHARMA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
6.98 -0.71 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 7.00
  • 26 Days 7.10
  • 10 Days 7.10
  • 50 Days 7.20
  • 12 Days 7.10
  • 100 Days 7.60
  • 20 Days 7.10
  • 200 Days 8.90
7.11 PIVOT
First Support 6.92 First Resistance 7.21 Second Support 6.82 Second Resistance 7.40 Third Support 6.63 Third Resistance 7.50
RSI 46.85 ADX 63.09 MACD -0.05 Williams % R -64.77 Commodity Channel Index (CCI) -26.69
Date 2024-11-26 Week 122953.00 Same Day 136793.00 Month 158529.00
1 Year 1.19 3 Year 0.86
Over 1 Month
-5.38% down
Over 1 Year
-44.51% down
Over 3 Months
3.53% down
Over 3 Years
-19.78% down
Over 6 Months
-19.84% down
Over 5 Years
14.25% down

VAISHALI PHARMA LIMITED Corporate Actions

Ex-Date Ex-Bonus Ratio
15 Oct 2024 15 Oct 2024 1:1
18 Oct 2019 17 Oct 2019 3:5
Ex-Date Old FV NEW FV Record Date
15 Oct 2024 10.0 2.0 15 Oct 2024
Ex-Date Ex-Bonus Ratio
15 Oct 2024 15 Oct 2024 1:1
18 Oct 2019 17 Oct 2019 3:5
Ex-Date Old FV NEW FV Record Date
15 Oct 2024 10.0 2.0 15 Oct 2024

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vaishali Pharma Ltd?

Answer Field

Vaishali Pharma Ltd share price is for NSE ₹ 7.19 & for BSE ₹ 0.00 as on Jun 03 2026 12:40 PM.

What is the Market Cap of Vaishali Pharma Ltd Share?

Answer Field

The market cap of Vaishali Pharma Ltd for NSE ₹ 91.10 & for BSE ₹ 0.00 as on Jun 03 2026 12:40 PM.

What is the 52 Week High and Low of Vaishali Pharma Ltd?

Answer Field

The 52 Week High and Low of Vaishali Pharma Ltd for NSE is ₹ 13.59 and ₹ 4.75 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Vaishali Pharma Ltd?

Answer Field

The 1 year returns on the stock has been -44.51%.

What is the P/E Ratio of Vaishali Pharma Ltd Share?

Answer Field

As on Jun 03 2026 12:40 PM the price-to-earnings (PE) ratio for Vaishali Pharma Ltd share is -175.75.

What is the PB ratio of Vaishali Pharma Ltd Share?

Answer Field

As on Jun 03 2026 12:40 PM, the price-to-book (PB) ratio for Vaishali Pharma Ltd share is 5.16.

How to Buy Vaishali Pharma Ltd Share?

Answer Field

You can trade in Vaishali Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vaishali Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Vaishali Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vaishali Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|